Mirum Pharmaceuticals, Inc. (MIRM) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MIRM currently has 58.9M outstanding shares. with moderate dilution risk from 17.6M authorized shares representing 30.0% potential dilution. The company has diluted shareholders by 23.8% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 58.9M shares outstanding |
59M | 18M |
| Nov 04, 2025 |
10-Q filing | 50.6M shares outstanding |
51M | 18M |
| Aug 06, 2025 |
10-Q filing | 49.7M shares outstanding |
50M | 18M |
| May 07, 2025 |
10-Q filing | 48.9M shares outstanding |
49M | 18M |
| Feb 26, 2025 |
10-K filing | 47.5M shares outstanding |
48M | 18M |
| Nov 12, 2024 |
10-Q filing | 47.8M shares outstanding |
48M | 18M |
| Aug 07, 2024 |
10-Q filing | 47.2M shares outstanding |
47M | 18M |
| May 08, 2024 |
10-Q filing | 46.9M shares outstanding |
47M | 18M |
| Mar 15, 2024 |
10-K filing | 47.0M shares outstanding |
47M | 18M |
| Nov 02, 2023 |
10-Q filing | 46.6M shares outstanding |
47M | 18M |
| Aug 07, 2023 |
10-Q filing | 38.1M shares outstanding |
38M | 18M |
| May 04, 2023 |
10-Q filing | 37.7M shares outstanding |
38M | 18M |
| Mar 08, 2023 |
10-K filing | 38.0M shares outstanding |
38M | 18M |
| Nov 09, 2022 |
10-Q filing | 34.9M shares outstanding |
35M | 18M |
| Aug 04, 2022 |
10-Q filing | 32.2M shares outstanding |
32M | 18M |
| May 25, 2022 |
S-3 filing: This S-3 filing pertains to the resale of up to 841,792 shares of common stock by selling stockholders. |
32M | 18M |
| May 05, 2022 |
10-Q filing | 31.8M shares outstanding |
32M | 17M |
| Mar 09, 2022 |
10-K filing | 31.7M shares outstanding |
32M | 17M |
| Nov 15, 2021 |
10-Q filing | 30.6M shares outstanding |
31M | 17M |
| Aug 05, 2021 |
10-Q filing | 30.5M shares outstanding |
31M | 17M |
| May 06, 2021 |
10-Q filing | 30.5M shares outstanding |
30M | 17M |
| Mar 09, 2021 |
10-K filing | 30.4M shares outstanding |
30M | 17M |
| Nov 12, 2020 |
10-Q filing | 25.7M shares outstanding |
26M | 17M |
| Aug 10, 2020 |
S-3/A filing: The filing is for a shelf offering of common stock, preferred stock and debt securities, with a total proposed amount of $300,000,000. |
25M | 17M |
| Aug 06, 2020 |
10-Q filing | 25.4M shares outstanding |
25M | 17M |
| Aug 03, 2020 |
S-3 filing: The company may offer up to $300,000,000 of any combination of common stock, preferred stock and debt securities from time to time. |
25M | 17M |
| May 07, 2020 |
10-Q filing | 25.4M shares outstanding |
25M | 2.8M |
| Mar 12, 2020 |
10-K filing | 25.4M shares outstanding |
25M | 2.8M |
| Jan 06, 2020 |
S-1 filing: This S-1 filing includes information on the offering of common stock. |
25M | 2.8M |